Navigation Links
Drug-Eluting Stents Show Promise for Leg Arteries
Date:3/10/2009

Fewer repeat procedures were needed in people with peripheral arterial disease, study finds,,

TUESDAY, March 10 (HealthDay News) -- Treating peripheral arterial disease with drug-eluting stents may save lives and limbs in people with severely obstructed arteries, Greek researchers have found.

Peripheral arterial disease is common in the lower extremities and sometimes leads to severe obstructions, known as critical limb ischemia (CLI), a condition in which the decreased blood flow causes pain and skin ulcers.

"CLI is today a major health problem, especially in Western societies, and is associated with high morbidity and mortality rates," said Dimitris Karnabatidis, the lead researcher and an assistant professor of interventional radiology at Patras University Hospital in Rion, Greece. "More specifically, an estimated 1 percent of the worldwide population over 50 years old suffers from CLI."

Karnabatidis' study involved 103 people, three-fourths of them diabetics. A normal stent -- a wire mesh tube used to prop open an artery -- was placed in an artery in 41 participants, and 62 were given drug-eluting stents, which were stents coated with sirolimus, an immunosuppressant.

After three years, the researchers found that people with drug-eluting stents had more open arteries (higher primary patency) and less renarrowing (binary restenosis), and they were less likely to need a repeat procedure. People with atherosclerotic disease, or narrowing of the arteries, often must undergo multiple surgical procedures to repair renarrowed arteries at the site of angioplasty or stenting, the researchers said.

"After having such a good experience with drug-eluting stents in the coronary system, there's been enthusiasm about using them in legs," said Dr. Kirk Garratt, director of clinical research at Lenox Hill Heart and Vascular Institute of New York. "We've traditionally used balloons to get these vessels ope
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Promising Three-year Data: Saving Limbs With Drug-Eluting Stents
2. Boston Scientific Announces Japanese Launch of Taxus(R) Liberte(R) Drug-Eluting Stent System
3. SYNTAX defines borders between CABG and PCI with TAXUS drug-eluting stents
4. Drug-Eluting Stents Beat Bare Metal Stents in Diabetics
5. Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter
6. Drug-Eluting Stents Safe After Heart Attack
7. The Lancet publishes first clinical trial data of a fully bioabsorbable drug-eluting stent
8. XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
9. TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
10. Noninvasive screening test may detect narrowing in intracranial stents
11. Efficacy of stents is improved when their placement is determined by arterial blood flow measurement
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug-Eluting Stents Show Promise for Leg Arteries
(Date:5/5/2015)... " QuickPick Travel ” was featured on NewsWatch as ... small, medium, and large businesses making an impact in their ... expert, conducted the business review and shared with viewers how ... weeks of vacation for free. , Vacations are a sought-after ... world. And when people are preparing for vacations, they’re used ...
(Date:5/5/2015)... This year, PolyU researchers garnered two ... Awards, three Gold Medals and four Silver Medals at ... follows: , (1) Grand Prize and Gold Medal with ... Design and Fitting, Principal Investigator: Dr Allan Chee-kooi CHAN, ... relies very much on the “mannequin” for many tasks ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 ... mission-focused company serving the federal government, today announced ... (CCSi). CCSi provides solutions exclusively to federal ... extensive experience in cyber security, health services, and ... processes and industry-relevant credentials as a Third Party ...
(Date:5/5/2015)... The brains of people with type ... with slower information processing, according to research led by ... Health . , The findings indicate that clinicians ... for cognitive difficulties. If progressive, these changes could influence ... by the National Institutes of Health (NIH), ...
(Date:5/5/2015)... Washington, DC (PRWEB) May 05, 2015 ... Amplify Hope Initiative, a new study aimed at determining ... disease patients. RG is an international non-profit providing rare ... genomics sequencing technology, connections to scientists and researchers, and ... or crowdfunding. , “I am excited to see how ...
Breaking Medicine News(10 mins):Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 3Health News:PolyU wins top prizes in Geneva’s Invention Expo 4Health News:PolyU wins top prizes in Geneva’s Invention Expo 5Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4Health News:Rare Genomics Institute to Study Impact of Crowdfunding on Rare Diseases 2
... New research released to mark No Smoking Day (11 March) ... in Great Britain are thinking,about or planning to cut down or ... shows that one in ten (9%) will be taking the first,step ... No Smoking Day President and Dragons, Den star, ...
... , , TUESDAY, March 10 (HealthDay News) -- Used together, a ... in detecting ovarian cancer in its early and more curable ... become a new standard in the fight against this deadly ... to be an approach that may be workable," said Robert ...
... state budget maintains charity care spending levelMARLTON, N.J., March ... Virtua Health, praised New Jersey Governor Jon Corzine, Health ... for placing a high priority on the health care ... that was unveiled today in Trenton.In the state fiscal ...
... ARBOR, Mich.---Biomedical and materials engineers at the University ... brain implants that helps the devices operate longer ... epilepsy and Parkinson,s disease. , Currently, brain implants ... and the next generation of the devices operate ...
... A recent CBS 60 Minutes TV program drew ... molecule believed to largely be responsible for the ... more people living beyond 100 years and exhibit ... than other people living in other developed countries, ...
... people with peripheral arterial disease, study finds, , , ... arterial disease with drug-eluting stents may save lives ... Greek researchers have found. , Peripheral arterial disease ... leads to severe obstructions, known as critical limb ...
Cached Medicine News:Health News:Recession leads 1 in 3 Smokers to cut Down or Quit 2Health News:Recession leads 1 in 3 Smokers to cut Down or Quit 3Health News:Combo of Tests Might Spot Ovarian Cancer Early 2Health News:Combo of Tests Might Spot Ovarian Cancer Early 3Health News:Virtua Commends Gov. Corzine's Charity Care Funding Plan 2Health News:Nanotech coating could lead to better brain implants to treat diseases 2Health News:Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R) 2Health News:Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R) 3Health News:Drug-Eluting Stents Show Promise for Leg Arteries 2Health News:Drug-Eluting Stents Show Promise for Leg Arteries 3
(Date:5/5/2015)... , May 5, 2015  Astellas announced that two ... one abstract detailing clinical data from a study of ... presented during a late breaking plenary session at the ... on May 17 in New Orleans, Louisiana ... Phase 2 studies designed to evaluate enzalutamide compared to ...
(Date:5/5/2015)... MINNEAPOLIS , May 5, 2015 Bio-Techne ... of Directors has decided to pay a dividend of ... 2015. The quarterly dividend will be payable May 29, ... 15, 2015.  Future cash dividends will be considered by ... Bio-Techne Corporation (NASDAQ: TECH ) is a ...
(Date:5/5/2015)... -- - No one has covered cath ... ABMRG - Primary research covering 700 angioplasty ... among states & regions; hospital chains; govt. & pvt. ... coronary stent market in India , ... (BMS) and Bio-Absorbable Stent (BVS), was valued above $400 ...
Breaking Medicine Technology:Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 2Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 3Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 4Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 5Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 6Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 7Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 8Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 9India Coronary Stent Market to be Tripled by 2021 2India Coronary Stent Market to be Tripled by 2021 3India Coronary Stent Market to be Tripled by 2021 4
... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced ... on Tuesday, May 8, 2012 at 4:30 p.m. EDT/9:30 p.m. ... and financial update and review first quarter 2012 results. ... from the Investors section of the Jazz Pharmaceuticals website at ...
... IRVINE, Calif., April 30, 2012  PRO-DEX, INC. (Nasdaq: ... in management,s broadcast review of the Company,s fiscal 2012 ... ) The conference call is scheduled ... May 4, 2012 at 4:30 p.m. Eastern Time (1:30 ...
Cached Medicine Technology:Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast 2
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
Classic proven design with superior clinical results....
The Perfecta PDA components provide the design and material choice imperative in today's cost conscious medical climate....
Cementless hip stem revisions offering optimal version setting for each patient. Compatible with modular link ceramic or cobalt chromium femoral heads with up to 4 neck lengths, or the link saddle de...
Medicine Products: